Topical corticosteroid use during pregnancy.
نویسندگان
چکیده
QUESTION Some of my pregnant patients have been prescribed various potencies of topical corticosteroids. Do these carry the same fetal risks as systemic corticosteroids? ANSWER Pregnant women can be reassured that there is no apparent increased risk of adverse fetal effects when using topical corticosteroids during pregnancy, although some data do suggest fetal growth restriction with more potent topical corticosteroids. Overall, women should be prescribed the lowest potency required whenever possible.
منابع مشابه
Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study.
IMPORTANCE Topical corticosteroids are indicated for pregnant women with skin conditions, but their safety in pregnancy is not fully understood. OBJECTIVE To investigate whether maternal exposure to topical corticosteroids results in adverse pregnancy outcomes. DESIGN Retrospective cohort study. SETTING United Kingdom National Health Service. PARTICIPANTS A total of 2658 pregnant women ...
متن کاملTreatment of Vogt-Koyanagi- Harada's disease during pregnancy.
BACKGROUND Caution should be exercised in treating patients with autoimmune diseases during pregnancy. CASES We successfully treated three cases of Vogt-Koyanagi-Harada's disease (VKH disease) during pregnancy. OBSERVATIONS In the second trimester (14-27 weeks) of 1 patient, inflammation was mild and could be treated by topical corticosteroid. There is the possibility that her immune respon...
متن کاملIatrogenic Cushing\'s Syndrome Due to Cutaneous Corticosteroid Therapy
Summary A case of Cushing' s syndrome associated with application of topical clobetasol propionate (0.05%) is reported. Local application of clobetasol propionate is associated with adrenal suppression in normal subjects and on this basis, it has been recommended that less than 50 g per week be used. There have been sporadic case reports of cushing's syndrome associated with topical steroid bu...
متن کاملSuccessful treatment of major pemphigus vulgaris relapse with mycophenolate mofetil and high-potent topical corticosteroid
Background: Pemphigus vulgaris (PV) is an autoimmune bullous disorder that is fatal if left untreated. High dose systemic corticosteroids are the basis of therapy. The addition of immunosuppressive agents has improved the disease outcome and reduced the required corticosteroid dose and related toxicity. Mycophenolate mofetil is increasingly used as a steroid-sparing agent in immunotherapy of PV...
متن کاملEarly resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease: a case report
BACKGROUND At present, there is no standard of treatment using systemic high-dose corticosteroids in cases of pregnant women with Vogt-Koyanagi-Harada (VKH) disease. Although high-dose systemic corticosteroid treatment is often used for VKH disease during pregnancy, it also poses a risk to the fetus. FINDINGS A 29-year-old woman in the 34th week of pregnancy experienced bilateral metamorphops...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Canadian family physician Medecin de famille canadien
دوره 58 6 شماره
صفحات -
تاریخ انتشار 2012